Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ReWalk Robotics Ltd (RWLK : NSDQ)
 
 • Company Description   
ReWalk Robotics Ltd. develops, manufactures and markets wearable robotic exoskeletons for individuals with spinal cord injury. The Company's exoskeletons allow wheelchair-bound individuals with mobility impairments or other medical conditions the ability to stand and walk once again. It offers ReWalk Personal for everyday use to individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy to individuals with lower limb disabilities in the clinical rehabilitation environment. ReWalk Robotics Ltd. is headquartered in Yokneam Ilit, Israel.

Number of Employees: 51

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.94 Daily Weekly Monthly
20 Day Moving Average: 326,872 shares
Shares Outstanding: 62.51 (millions)
Market Capitalization: $58.53 (millions)
Beta: 2.73
52 Week High: $2.78
52 Week Low: $0.85
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -17.87% -10.37%
12 Week -13.31% -8.73%
Year To Date -23.88% -11.27%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
3 Hatnufa Street Floor 6
-
Yokneam Ilit,L3 2069203
ISR
ph: 972-4959-0123
fax: -
ir@rewalk.com http://www.rewalk.com
 
 • General Corporate Information   
Officers
Larry Jasinski - Chief Executive Officer and Director
Jeff Dykan - Chairman of the Board
Ori Gon - Chief Financial Officer
Yohanan R Engelhardt - Director
Dr. John William Poduska - Director

Peer Information
ReWalk Robotics Ltd (ABMD)
ReWalk Robotics Ltd (DMDS)
ReWalk Robotics Ltd (CPWY.)
ReWalk Robotics Ltd (EQUR)
ReWalk Robotics Ltd (ECIA)
ReWalk Robotics Ltd (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: M8216Q200
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/08/22
Share - Related Items
Shares Outstanding: 62.51
Most Recent Split Date: 4.00 (0.04:1)
Beta: 2.73
Market Capitalization: $58.53 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.05 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.21 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/08/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.69
Price/Cash Flow: -
Price / Sales: 10.59
EPS Growth
vs. Year Ago Period: 12.50%
vs. Previous Quarter: -16.67%
Sales Growth
vs. Year Ago Period: -33.43%
vs. Previous Quarter: -29.47%
ROE
03/31/22 - -16.81
12/31/21 - -16.05
09/30/21 - -18.93
ROA
03/31/22 - -15.79
12/31/21 - -14.99
09/30/21 - -17.32
Current Ratio
03/31/22 - 24.26
12/31/21 - 22.91
09/30/21 - 21.99
Quick Ratio
03/31/22 - -
12/31/21 - 22.17
09/30/21 - 21.29
Operating Margin
03/31/22 - -253.78
12/31/21 - -213.48
09/30/21 - -198.97
Net Margin
03/31/22 - -253.78
12/31/21 - -213.48
09/30/21 - -198.97
Pre-Tax Margin
03/31/22 - -252.21
12/31/21 - -211.90
09/30/21 - -198.87
Book Value
03/31/22 - 1.36
12/31/21 - 1.43
09/30/21 - 1.49
Inventory Turnover
03/31/22 - 0.97
12/31/21 - 0.95
09/30/21 - 0.88
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©